59 related articles for article (PubMed ID: 16967334)
1. Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic.
Olivero G; Roggeri A; Pittaluga A
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834353
[TBL] [Abstract][Full Text] [Related]
2. Anti-AMPA Receptor Autoantibodies Reduce Excitatory Currents in Rat Hippocampal Neurons.
Day C; Silva JP; Munro R; Baker TS; Wolff C; Bithell A; Stephens GJ
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678574
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights.
Levite M; Goldberg H
Front Immunol; 2021; 12():762743. PubMed ID: 35095841
[TBL] [Abstract][Full Text] [Related]
4. Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.
Hansen KB; Wollmuth LP; Bowie D; Furukawa H; Menniti FS; Sobolevsky AI; Swanson GT; Swanger SA; Greger IH; Nakagawa T; McBain CJ; Jayaraman V; Low CM; Dell'Acqua ML; Diamond JS; Camp CR; Perszyk RE; Yuan H; Traynelis SF
Pharmacol Rev; 2021 Oct; 73(4):298-487. PubMed ID: 34753794
[TBL] [Abstract][Full Text] [Related]
5. Antibodies Against the NH
Cisani F; Olivero G; Usai C; Van Camp G; Maccari S; Morley-Fletcher S; Pittaluga AM
Front Immunol; 2021; 12():586521. PubMed ID: 33717067
[TBL] [Abstract][Full Text] [Related]
6. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features.
Gardoni F; Stanic J; Scheggia D; Benussi A; Borroni B; Di Luca M
Cells; 2021 Jan; 10(1):. PubMed ID: 33466431
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in Neuropsychiatric Disorders.
Hoffmann C; Zong S; Mané-Damas M; Molenaar P; Losen M; Martinez-Martinez P
Antibodies (Basel); 2016 Apr; 5(2):. PubMed ID: 31557990
[TBL] [Abstract][Full Text] [Related]
8. Antibodies as Mediators of Brain Pathology.
Brimberg L; Mader S; Fujieda Y; Arinuma Y; Kowal C; Volpe BT; Diamond B
Trends Immunol; 2015 Nov; 36(11):709-724. PubMed ID: 26494046
[TBL] [Abstract][Full Text] [Related]
9. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
10. Brain-reactive antibodies and disease.
Diamond B; Honig G; Mader S; Brimberg L; Volpe BT
Annu Rev Immunol; 2013; 31():345-85. PubMed ID: 23516983
[TBL] [Abstract][Full Text] [Related]
11. Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice.
Adriani W; Koot S; Columba-Cabezas S; Romano E; Travaglini D; van den Bos R; Granstrem O; Ali SF; Laviola G
Behav Brain Funct; 2012 Nov; 8():54. PubMed ID: 23192105
[TBL] [Abstract][Full Text] [Related]
12. Dynamics and allosteric potential of the AMPA receptor N-terminal domain.
Sukumaran M; Rossmann M; Shrivastava I; Dutta A; Bahar I; Greger IH
EMBO J; 2011 Mar; 30(5):972-82. PubMed ID: 21317871
[TBL] [Abstract][Full Text] [Related]
13. Losing your nerves? Maybe it's the antibodies.
Diamond B; Huerta PT; Mina-Osorio P; Kowal C; Volpe BT
Nat Rev Immunol; 2009 Jun; 9(6):449-56. PubMed ID: 19424277
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and pathogenic significance of glutamate receptor autoantibodies.
Pleasure D
Arch Neurol; 2008 May; 65(5):589-92. PubMed ID: 18474732
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice.
Capone F; Adriani W; Shumilina M; Izykenova G; Granstrem O; Dambinova S; Laviola G
Psychopharmacology (Berl); 2008 May; 197(4):535-48. PubMed ID: 18265961
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels.
Cohen-Kashi Malina K; Ganor Y; Levite M; Teichberg VI
Neurochem Res; 2006 Oct; 31(10):1181-90. PubMed ID: 16967334
[TBL] [Abstract][Full Text] [Related]
17. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
Levite M; Fleidervish IA; Schwarz A; Pelled D; Futerman AH
J Autoimmun; 1999 Aug; 13(1):61-72. PubMed ID: 10441169
[TBL] [Abstract][Full Text] [Related]
19. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
Watson R; Jiang Y; Bermudez I; Houlihan L; Clover L; McKnight K; Cross JH; Hart IK; Roubertie A; Valmier J; Hart Y; Palace J; Beeson D; Vincent A; Lang B
Neurology; 2004 Jul; 63(1):43-50. PubMed ID: 15249609
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
